Search

Search Constraints

You searched for: Record Type Journal Article Author/Creator Yoshiji, Hitoshi

Search Results

11. Blocking development of liver fibrosis augments hepatic progenitor cell‐derived liver regeneration in a mouse chronic liver injury model. Issue 9 (29th May 2019)

12. Cell‐free and concentrated ascites reinfusion therapy versus large‐volume paracentesis for the treatment of cirrhotic patients with refractory ascites: A multicenter prospective observational study. Issue 3 (3rd December 2022)

13. Clinical characteristics of immunoglobulin IgG4-related sclerosing cholangitis: Comparison of cases with and without autoimmune pancreatitis in a large cohort. Issue 10 (October 2021)

14. Clinical features of liver cirrhosis patients with muscle cramping: a multicenter study. Issue 12 (December 2019)

15. Clinical features of patients with chronic liver disease in Japan related to alcohol use: Nationwide examination using alcohol use disorders identification test. Issue 1 (15th September 2022)

16. Combined effect of a farnesoid X receptor agonist and dipeptidyl peptidase‐4 inhibitor on hepatic fibrosis. Issue 10 (15th July 2019)

17. Combined treatment with dipeptidyl peptidase‐4 inhibitor (sitagliptin) and angiotensin‐II type 1 receptor blocker (losartan) suppresses progression in a non‐diabetic rat model of steatohepatitis. Issue 12 (13th February 2017)

18. Cross talk between toll‐like receptor‐4 signaling and angiotensin‐II in liver fibrosis development in the rat model of non‐alcoholic steatohepatitis. Issue 4 (25th March 2013)

19. Cross‐over study in hyperammonemia patients for efficacy, safety, and acceptability of a new lactulose preparation (SK‐1202) compared to approved drug. Issue 13 (9th August 2018)

20. Diagnostic criteria for acute‐on‐chronic liver failure and related disease conditions in Japan. Issue 5 (19th May 2022)